跳至主要内容
临床试验/CTRI/2024/06/069362
CTRI/2024/06/069362尚未招募不适用

Role of microalbuminuria and creatinine in the obese and non-obese subject

Datta Meghe Institute of Higher Education and Research1 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2024年7月17日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
78
试验地点
1
主要终点
All early renal failure patients expected to have their microalbuminuria levels checked, and these levels expected to be significantly greater in early renal failure patients.

研究概览

简要总结

Introduction : : Microalbuminuria refers to an elevated excretion rate of albumin in the urine, ranging from 30 to 299 mg/g creatinine in measurement. It raises the chances of heart disease and death and shows issues with how the blood vessels function. Serum creatinine is a commonly studied substance in clinical chemistry labs worldwide. Assessing kidney function is aided by the creatinine test, while obesity raises the likelihood of developing CKD. **Need of the study :**To enhance patient care and results, it is crucial to examine the levels of microalbuminuria and creatinine in obese and non-obese patients. These researches can provide significant understanding of kidney health, metabolic function, and cardiovascular risk.

Aim: To study the role of microalbuminuria and creatinine in obese and non-obese subjects. Material and method : This protocol for study will be conducted in the Central Clinical Laboratory at the Biochemistry division of Department of Biochemistry of Acharya Vinoba Bhave Rural Hospital associated with Jawaharlal Nehru medical college situated in the state of Maharashtra,in india from November 2023 to October 2024. Patient between the age group of 10 years to 80 years will be taken. Total 78 patient will be taken ,39 will be a obese population and 39 will be a non-obese. 18 patients of microalbuminuria will be taken as cases and 17 creatinine were taken as controls. Before and throughout the trial, all ethical procedures were followed and written agreement was obtained. Patients with kidney disease bought to be considered for the trial. All Patients regardless of age or gender, who present with symptoms of microalbuminuria and creatinine will be included. The waist circumference of the young, obese patients—90 cm for men and 82 cm for women was used to determine their selection

研究设计

研究类型
Observational

入排标准

年龄范围
10.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • 1.This research will includes total 78 patients.
  • 2.Subjects of both sexes will be include.
  • 3.All patients, regardless of age or gender.
  • 4.Who present with symptoms of microalbuminuria and creatinine will be included.
  • 5.The waist circumference of the young, obese patients—90 cm for men and 82 cm for women was used to determine their selection.

排除标准

  • 1.History and /or laboratory data suggestive of Chronic kidney diseases.
  • Patients will be excluded if they are symptoms of urinary tract infection (UTI).
  • 3.Patient will be exclude if presence of leucocytes, nitrites, and blood found in urine.

结局指标

主要结局

All early renal failure patients expected to have their microalbuminuria levels checked, and these levels expected to be significantly greater in early renal failure patients.

时间窗: assessment will be done at the end of 12 month

次要结局

未报告次要终点

研究者

发起方
Datta Meghe Institute of Higher Education and Research
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Saurabh Anil Vighe

Jawaharlal Nehru Medical College Sawangi

研究点 (1)

Loading locations...

相似试验